← FDA DRUG APPROVALS

FDA NDA · NDA017700

GALLIUM CITRATE GA 67

Sponsor: GE HEALTHCARE

APPLICATION
NDA017700
TYPE
NDA
ORIGINAL APPROVAL
1977-12-16
LATEST ACTION
1979-08-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

GALLIUM CITRATE GA 67Discontinued
GALLIUM CITRATE GA-67 1mCi/ML · INJECTABLE · INJECTION

Approval history

1979-08-22Labeling · Supplement 2 · standardAP
1978-08-23Manufacturing (CMC) · Supplement 3 · standardAP
1978-08-23Manufacturing (CMC) · Supplement 1 · standardAP
1977-12-16Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →